• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Low-to-Moderate caffeine intake during pregnancy is not associated with increased risk of maternal cardiometabolic complications

byGursharan SohiandMichael Pratte
November 9, 2021
in Obstetrics, Pediatrics, Public Health
Reading Time: 4 mins read
0
Share on FacebookShare on Twitter

1. A cohort study of 2583 pregnant women found that low or moderate caffeine intake (<200mg/day) did not significantly increase the risk of maternal cardiometabolic complications including gestational diabetes, preeclampsia and gestational hypertension.

2. Low-moderate caffeine intake was associated with a lower risk of gestational diabetes mellitus and lower blood glucose levels during diabetes screening compared to no caffeine intake.

Evidence Rating Level: 2 (Good)

Study Rundown: Despite being one of the most commonly used substances worldwide, the effects of caffeine consumption in some populations remains poorly understood. Pregnant women in particular are recommended to intake no more than 200mg of caffeine per day, as high levels of daily caffeine consumption can increase the risk of pregnancy loss and fetal growth restriction. However, there remains mixed evidence for the role of low to moderate amounts of caffeine intake in pregnancy, creating confusion for patients and physicians alike. The present study sought to assess maternal cardiometabolic health outcomes in pregnant women who did, and did not consume low to moderate amounts of caffeine. 2583 pregnant women participated in this prospective cohort study, attending 4 study visits between weeks 16 and 37 of their pregnancy. Exposure to caffeine was assessed using women’s self-reported caffeinated-beverage intake as well as measurements of serum caffeine and paraxanthine levels. Race, nulliparity, education level, marital status, alcohol intake prior to pregnancy, perceived stress and diet were all significantly associated with the amount of daily caffeine intake. Caffeine intake between 1-100mg/day during weeks 16-22 of pregnancy was associated with decreased risk of gestational diabetes (GDM) and lower blood glucose compared to no intake. Neither caffeinated beverage intake or plasma caffeine concentration were associated with the development of gestational hypertension or preeclampsia. The present study by Hinkle et al provides an interesting overview of patterns of caffeine intake amongst pregnant women in the United States in addition to demonstrating its relative safety with regards to cardiometabolic outcomes in this population. They found that low to moderate daily caffeine intake had no bearing on blood pressure and may even be protective against hyperglycemia and GDM. A major drawback of the study was the relatively small sample size which may have made it difficult to detect associations with other, less common pregnancy complications. Additionally, selection of particularly healthy participants is not representative of the average American pregnant woman. The authors did well to conduct robust sensitivity analyses adjusting for employment, family history of diabetes, severe nausea/hyperemesis, pre pregnancy alcohol intake, stress, sleep, physical activity, diet and energy intake. The results of this study should be taken in context to reassure patients that low-moderate daily caffeine consumption is not overtly harmful during pregnancy, although further study of additional maternal and fetal outcomes is warranted.

Click to read this study in JAMA Network Open

Relevant Reading: Association of maternal caffeine intake during pregnancy with low birth weight, childhood overweight, and obesity: a meta-analysis of cohort studies

In-Depth [prospective cohort study]: This was a multi-centre prospective cohort study done in 12 sites across the United States. Participant data was derived from an existing cohort of pregnant women participating in a fetal growth study; the cohort composition overrepresented pregnant women of racial/ethnic minority groups. Patients were enrolled for the present study between weeks 8 and 13 of pregnancy. Exclusion criteria included: high or low BMI, smoking, alcohol consumption in pregnancy, use of assistive reproductive technology to conceive, pregnancy complications and chronic disease. Patients who dropped out of the study or who had missing data were found to be not significantly different from those analyzed in terms of caffeine intake and plasma caffeine. The most commonly consumed beverages amongst the caffeine-drinking cohort were as follows: soda (58.5%), coffee (40.6%), tea (32.1%) and energy drinks (0.5%). The significance of the following factors with amount of daily caffeine intake is given by p-values (in brackets) less than 0.05: race (0.002), nulliparity (<0.001), education level (0.002), marital status (<0.001), alcohol intake prior to pregnancy (<0.001), perceived stress (0.002) and diet (<0.001). The relative risk of GDM with caffeine intake between 1-100mg/day compared to no caffeine was 0.53 (95% confidence interval 0.35-0.80), with a risk reduction value of 47%. This exposure was also associated with lower blood glucose concentrations by 2.7mg/dL compared to no caffeine (95% confidence interval -5.4 to 0). These findings were robust to sensitivity analyses. Biochemical analysis completed in a subset of the sample found that plasma caffeine and paraxanthine in the fourth quartile at 10-13 weeks of pregnancy was not associated with GDM or impaired glucose tolerance, and that blood glucose concentrations were 3.8mg/dL (-7 to -0.5) lower compared to those in the first quartile. Caffeine intake between 16 and 22 weeks was also associated with improved markers of cardiometabolic health.

RELATED REPORTS

The 2 Minute Medicine Podcast Episode 11

The Scan by 2 Minute Medicine®: Erythritol and Heart Problems, Maternal Health Trends, the Next Big Thing in Diabetes, and Declining Levels of Sea Ice

Increased morbidity and mortality among pregnant women with Omicron-related COVID-19

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: caffeinecoffeepregnancypregnancy complications
Previous Post

#VisualAbstract: Internal mammary node irradiation improves survival for patients with centromedially located node-positive breast cancer

Next Post

Maralixibat appears safe and efficacious for patients with Alagille syndrome and cholestatic pruritus

RelatedReports

2MM Podcast

The 2 Minute Medicine Podcast Episode 11

March 23, 2023
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Erythritol and Heart Problems, Maternal Health Trends, the Next Big Thing in Diabetes, and Declining Levels of Sea Ice

March 7, 2023
Prenatal antidepressant exposure may increase risk of poor motor development
Infectious Disease

Increased morbidity and mortality among pregnant women with Omicron-related COVID-19

February 21, 2023
Prenatal antidepressant exposure may increase risk of poor motor development
Chronic Disease

Aspirin discontinuation at 24 to 28 weeks gestation does not affect preeclampsia in high-risk patients

February 21, 2023
Next Post
Spleen elastography may be effective in the diagnosis of portal hypertension

Maralixibat appears safe and efficacious for patients with Alagille syndrome and cholestatic pruritus

Novel coronavirus identified from patients with pneumonia in Wuhan, China

Inhaled and intranasal ciclesonide for the treatment of COVID-19 in adult outpatients

Novel coronavirus identified from patients with pneumonia in Wuhan, China

Immune thrombocytopenia and thrombosis mortality predictors following SARS-CoV-2 vaccine

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Addition of fludrocortisone to hydrocortisone is beneficial in management of septic shock
  • Surveillance testing of staff at nursing facilities reduces resident COVID-19 mortality
  • Childhood maltreatment may cause mental health problems
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options